Carlisle Companies Incorporated (NYSE: CSL) — A Dividend King’s Roof, Priced for the Recovery It Hasn’t Delivered Yet — Now Reaching for a Bet-the-Company Bid

Report date: 2026-07-04 · Sector: Industrials — Building Products (Commercial Roofing & Building Envelope) · SEC CIK 0000790051

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows takes no position and carries no price target; this block is the sole exception.

Verdict: HOLD / quality-at-a-full-price (~$367). Accumulate on weakness toward the ~$300–330 zone (~13x EV/EBITDA, ~18x adj. EPS); a re-test of the November-2025 ~$294 low would be a gift. Not a short — the business is too good. Tag: “A Dividend King’s roof, priced for a recovery it hasn’t shown yet — with a bet-the-company bid hanging over it.”

Carlisle is a genuinely excellent business wearing a demanding price and, as of ten days ago, carrying an uncharacteristic risk. The excellence is real: this is the North American leader in commercial single-ply roofing (EPDM/TPO/PVC membrane + polyiso), a business where ~70% of demand is non-discretionary re-roofing on a 20–25-year replacement cycle across an aging installed base — a genuine annuity with pricing power. Returns are strong (ROIC ~17%, CCM segment EBITDA margins ~27%), the balance sheet is conservative (net debt/EBITDA ~1.7x), capital allocation is best-in-class (share count cut from ~53M to ~41M since 2020, a 49-year dividend-increase streak that makes it a Dividend King), and management treats capital allocation “as a core competency, not a byproduct.” Over five years the stock has compounded at ~15%. If you could buy this at a fair multiple, you would.

But two things stop me from chasing it at ~$367. First, price. The stock sits at the 76th percentile of its own 10-year valuation range (~14x EV/EBITDA, ~21x adjusted EPS, ~6.5% FCF yield) — after a year in which adjusted EBITDA actually fell ~8% and adjusted EPS fell ~6% (FY2025: $17.16 vs $18.34). You are paying a premium multiple on trough-ish earnings for a recovery and a Vision-2030 doubling ($40 adj. EPS) that is still entirely a forecast; new construction remains soft, and the whole 2026 revenue guide is price, not volume. Second, the Owens Corning bid. On 2026-06-29 the WSJ reported Carlisle made multiple unsolicited offers for OC — “well over $10 billion” — and the stock fell, correctly: OC’s take-out EV at any real premium (~$19–21B) approaches or exceeds Carlisle’s entire market cap (~$15B). That is not a bolt-on; it is a bet-the-company deal that would blow through Carlisle’s cherished 1–2x leverage target and hand the market integration and overpayment risk. The single best thing about Carlisle — its capital discipline — is exactly what’s now in question.

Net: I want to own this roof, but not at 21x on a down year with a $10B question mark attached. Conviction: medium. Flips bullish if Carlisle walks away from OC disciplined (or structures it accretively) and commercial re-roofing volume re-accelerates off the winter-weather / soft-nonres trough. Flips bearish if it overpays for OC with heavy leverage/equity dilution, or the re-roofing demand base — the whole thesis — cracks. Framing: quality compounder at a full price in a cyclical soft patch, not a momentum trade (12-month relative strength is still negative) and not deep value.

📈 Stock Price Action — Five-Year Event Map

Factual price history, not a recommendation. Price moves are Fact; attributed drivers are Interpretation.

Over the trailing ~60 months Carlisle roughly doubled and then gave part of it back: from a ~$180 mid-2021 level, to a ~$471 all-time high (2024-10-14), down to a ~$294 52-week low (2025-11-20), and back to ~$367 (2026-07-02). The stock trades ~22% below its five-year high, inside a 52-week range of $293.64–$429.74, and its latest wobble is an M&A reaction, not a fundamental break. Beta ~1.05; five-year annualized total return ~15%, but the trailing 12 months are negative (~−6%).

Cycle narrative. (1) The 2021 run captured the post-COVID re-roofing and pricing surge plus the debt-funded Henry deal that created today’s CWT segment. (2) The early-2022 slide was a pure rate/affordability shock on a high-beta cyclical — nothing company-specific. (3) From mid-2022, Carlisle re-rated as record commercial-roofing margins held and the “Vision 2025” story (divest non-core CIT/CFT/CBF, become a pure-play building-envelope compounder) took hold. (4) The 2024 leg to an all-time-high $471 was the payoff: CIT sold to Amphenol for ~$2.025B, CCM margins at records, and one of the most aggressive buyback programs in the sector. (5) The −38% round-trip through 2025 was fundamental and cyclical — new construction (both resi and nonres) weakened, distributors destocked, petrochemical-linked raws (MDI, TPO resin, polyols) inflated faster than price, and adjusted EBITDA fell ~8%; the guide reset and the stock bottomed at $294 in November 2025. (6) From that low the stock rallied ~31% on visible margin recovery and reaffirmed Vision 2030 targets. (7) On 2026-06-29 the Carlisle→OC bid report knocked the acquirer down — the market’s verdict on a bet-the-company deal.

1. Executive Summary

Carlisle Companies is, since 2024, a pure-play building-envelope manufacturer — the product of a decade-long portfolio transformation that shed diversified-industrial businesses (Carlisle Brake & Friction, Carlisle Fluid Technologies, and, decisively, Carlisle Interconnect Technologies sold to Amphenol for ~$2.025B in 2024) to concentrate on two segments: Carlisle Construction Materials (CCM, ~72% of sales) — commercial single-ply roofing (EPDM/TPO/PVC membranes), polyiso insulation, and metal roofing/edge — and Carlisle Weatherproofing Technologies (CWT, ~28%) — waterproofing, air/vapor barriers, sealants, spray foam and block insulation, built largely on the 2021 Henry Company acquisition. FY2025: net sales $5,019.9M (roughly flat YoY), adjusted EBITDA $1,225.4M (24.4% margin, down 220bps), adjusted diluted EPS from continuing operations $17.16 (down ~6%), GAAP diluted EPS $17.15, and ~$970M of free cash flow.

The core proposition is high-quality and genuinely moaty, but the entry point is full and the near-term is soft:

• The moat is real and sits in commercial re-roofing. CCM is the U.S. leader in single-ply commercial membrane roofing; ~70% of its commercial-roofing revenue is re-roofing — replacement demand on a 20–25-year cycle across a large, aging installed base, with rising content per square foot as energy codes tighten. This is a defensible economies-of-scale + brand/specification moat (the “Carlisle Experience,” warranties, contractor lock-in) that supports ~27% CCM EBITDA margins and 17% ROIC. Verdict: durable moat.
• Economics are strong but cyclically pressured. ROIC ~17% (2025) sits comfortably above an ~8–9% WACC; gross margin expanded from ~29% (2020) to ~36% (2025). But 2025 was a down year — new-construction weakness plus petrochemical input inflation drove adjusted EBITDA −8% and margin −220bps. Capex is light (~2.6% of sales), so FCF conversion is excellent.
• Capital allocation is best-in-class. A 49-year dividend-increase streak (Dividend King), ~$1.3B of buybacks in 2025 alone (share count ~53M→41M since 2020), and disciplined bolt-on M&A (MTL, Plasti-Fab). This is the primary EPS engine and the reason to respect the franchise.
• Valuation is full and the tape has already recovered. At ~$367 the stock trades ~14x EV/EBITDA and ~21x adjusted EPS — the 76th percentile of its own 10-year range — on lower 2025 earnings. The market is underwriting the recovery and Vision 2030 ($40 adj. EPS, 25%+ ROIC by 2030).
• The wild card is the Owens Corning bid. On 2026-06-29, Carlisle was reported to have made multiple unsolicited >$10B offers for OC (residential shingles + fiberglass insulation). It would be transformative and complementary — but bet-the-company in scale, and OC is unreceptive. It puts Carlisle’s single greatest asset — capital discipline — on trial.

This report takes no position and sets no price target; the valuation discussion is framed strictly as embedded expectations and scenarios.

2. Business Overview

Carlisle Companies Incorporated (founded 1917; headquartered in Scottsdale, Arizona; ~11,000 employees) is today a focused building-envelope manufacturer operating through two reportable segments. This is a very different company than it was five years ago: management executed “Vision 2025,” systematically divesting its diversified-industrial legacy (Brake & Friction, Fluid Technologies, and the ~$2B-revenue Interconnect Technologies electronics business, sold to Amphenol in 2024) to become a pure-play on the North American building envelope. Over 90% of revenue is generated in North America — a deliberate feature management cites as a durability advantage.

FY2025 segment economics (10-K; segment profit measure is adjusted EBITDA):

(Q1-26 run-rate: CCM $758M @ 27.4% margin; CWT $294M @ 15.2% margin — CCM is ~72% of sales and the overwhelming majority of profit.)

Carlisle Construction Materials (CCM) is the profit engine and the moat. It manufactures single-ply commercial roofing membranes — EPDM (the category Carlisle pioneered in the 1960s), TPO (thermoplastic polyolefin, the fastest-growing membrane), and PVC — sold under the Carlisle SynTec, Versico, and WeatherBond brands; polyiso insulation (Hunter Panels / SecurShield); and metal roofing and edge-metal systems (MTL brands). The critical structural fact management stresses repeatedly: ~70% of CCM’s commercial-roofing revenue is re-roofing (replacement), not new construction. A commercial roof lasts ~20–25 years and then must be replaced regardless of GDP, giving CCM a large, non-discretionary, recurring demand base — the closest thing to an annuity in building products. Products are sold through a network of authorized sales representatives and distributors (Beacon/QXO, SRS, ABC Supply, etc.) to roofing contractors, with brand pull-through driven by long-dated warranties, specification wins with architects/building owners, and the service reliability Carlisle markets as the “Carlisle Experience.”

Carlisle Weatherproofing Technologies (CWT) is the younger, lower-margin, more residential-and-new-construction-exposed segment, built primarily on the 2021 Henry Company acquisition (~$1.57B) and bolt-ons (Bonded Logic, ThermaFoam, MTL, Plasti-Fab). It sells waterproofing and moisture-protection products, fully-integrated air/vapor barriers, sealants and flashings, spray polyurethane foam, and EPS block insulation under Henry, Resitrix, Hertalan, WeatherBond and other brands. CWT’s ~15% margins are well below CCM’s; management’s stated goal is to push CWT to ~20% in 2026 and “mid-20s” over time via footprint consolidation, automation, in-sourcing (e.g., in-house EPS resin from Plasti-Fab), and integration synergies — a self-help margin story that is a meaningful swing factor for the consolidated numbers.

The transformation is the context for everything. A decade ago Carlisle was a diversified industrial conglomerate — brakes and friction, fluid-handling/finishing equipment, aerospace interconnect wiring, and building products under one roof. Under CEO Chris Koch, management executed a deliberate “Vision 2025” simplification: it divested Carlisle Brake & Friction (2021), Carlisle Fluid Technologies (2022), and — the capstone — sold the ~$2B-revenue Carlisle Interconnect Technologies electronics business to Amphenol for ~$2.025B in cash (closed May 2024), while redeploying proceeds into building-envelope bolt-ons (Henry 2021, MTL and Plasti-Fab 2024) and buybacks. The result is today’s two-segment pure-play. This matters for three reasons: (i) it makes multi-year financials non-comparable (revenue base reset; 2024 GAAP EPS distorted by the CIT gain); (ii) it concentrated the portfolio into higher-margin, higher-return, more-focused building products (a genuine quality upgrade); and (iii) it established management’s pattern — decisive, value-creating portfolio surgery — which is exactly the reputation now being wagered on the Owens Corning approach. The company that cleanly exited four businesses is the same one now reaching to add a fifth larger than any before.

Revenue character. Carlisle is a manufacturer — revenue is transactional, not subscription. But the re-roofing replacement base gives CCM an annuity-like demand floor uncommon in building products, and warranties create a multi-decade relationship with building owners. Demand splits roughly into recurring re-roof (defensive) and new-construction (cyclical, currently weak).

Customer concentration is material and rising. Per the FY2025 10-K, the two largest customers together represented ~33% of consolidated revenues, and “the loss of either of these customers could have a material adverse effect.” These are large roofing/building-products distributors (the channel has consolidated sharply — QXO acquired Beacon; SRS was bought by Home Depot), which concentrates buyer power and is a genuine, if manageable, vulnerability.

Verdict: A focused, market-leading North American building-envelope franchise with a dominant, high-margin, recurring-demand profit engine (CCM commercial re-roofing) and a lower-margin, self-help-driven second segment (CWT). Transactional and partly cyclical, but cushioned by the re-roofing replacement base and ~90%+ North American footprint.

3. Industry Dynamics

Carlisle operates primarily in U.S. commercial roofing and the building envelope — a set of sub-industries with attractive structural features, currently at a soft point in the cycle.

Commercial single-ply roofing — structurally attractive. The U.S. commercial roofing market is large (~$20B+ including materials and installation) and consolidated at the membrane-manufacturer level. In single-ply membranes (EPDM/TPO/PVC — now the dominant low-slope commercial roofing technology), the field is an oligopoly: Carlisle (SynTec/Versico/WeatherBond) is the leader or co-leader, alongside Holcim’s Elevate (formerly Firestone Building Products, acquired by Holcim in 2021), GAF Commercial (Standard Industries), Johns Manville (Berkshire Hathaway), and Mule-Hide. These scaled, vertically-integrated manufacturers set the pricing and innovation agenda. The decisive structural feature — echoed by management — is that ~70% of demand is re-roofing/replacement, non-discretionary and tied to a 20–25-year roof-life cycle on a large installed base rather than to GDP or housing starts. Two secular tailwinds reinforce it: (i) an aging installed base of roofs approaching replacement, and (ii) rising content per square foot as energy codes mandate more insulation (polyiso) and higher-performance systems. Key inputs are petrochemical derivatives (MDI, TPO/propylene, polyols, asphalt) — crude-oil-linked and volatile, but broadly passed through with a lag via industry-wide price increases. Verdict: one of the more attractive building-products sub-industries — consolidated, replacement-driven, rational on price, secularly growing content.

Polyiso insulation & metal roofing — solid adjacencies. Polyiso (rigid board insulation for commercial roofs) is a consolidated market (Carlisle/Hunter, Holcim/GAF, Johns Manville, Atlas) that rides the same commercial-roofing demand and the energy-code content tailwind. Metal roofing/edge (MTL) is a fragmented, higher-growth niche Carlisle is consolidating via M&A. Both are capital-light relative to fiberglass insulation.

Waterproofing / building envelope (CWT markets) — fragmented and more cyclical. Air/vapor barriers, sealants, spray foam, waterproofing and EPS block insulation are more fragmented, more competitive, more residential-and-new-construction-exposed, and lower-margin than commercial roofing — which is exactly why CWT earns ~15% vs CCM’s ~27%. The secular driver (energy-efficient, code-compliant building envelopes) is favorable; the near-term (soft residential and nonres new construction) is not.

Where we are in the cycle (Marathon capital-cycle read). The industry is in a demand soft patch, not a supply glut. New construction — both residential and nonresidential — is weak on higher-for-longer rates; the Architecture Billings Index has hovered just below 50 (Q1-26 ~49.8). Distributors destocked through late 2025. But the re-roofing base is holding (low-single-digit growth), and there is no evidence of destabilizing capacity entry — the scaled incumbents are defending share and pushing price to offset input inflation. This is the attractive configuration: an oligopoly weathering a demand dip without a capital-cycle-destroying supply response.

Membrane dynamics and the strategic logic of the OC bid. Within single-ply, TPO has been taking share from EPDM and PVC for a decade (lower installed cost, reflective “cool-roof” energy performance, weldable seams) — a favorable mix for Carlisle, which is scaled across all three chemistries plus the polyiso insulation that goes underneath them. Crucially, Carlisle plays in commercial low-slope roofing, not residential asphalt shingles — the shingle market (GAF #1, Owens Corning #2) is an adjacent but distinct oligopoly Carlisle does not serve. That adjacency is the entire strategic rationale for the reported Owens Corning approach: OC would hand Carlisle the #2 U.S. residential-shingle franchise plus North America’s #1 fiberglass-insulation position — complementary, not overlapping, expanding Carlisle from “commercial building envelope” to “the whole roof, commercial and residential.” The industrial logic is real; the financial execution (a target whose take-out EV rivals Carlisle’s own market cap, at ~2x Carlisle’s EBITDA multiple) is what makes it perilous. It also tells you something about where management thinks organic growth has topped out: reaching for OC is an admission that Vision 2030’s ~$40 EPS is hard to hit on bolt-ons and buybacks alone.

Verdict (industry): Structurally good, cyclically soft. Commercial re-roofing is a genuinely attractive, defensive, consolidated sub-industry; the building-envelope adjacencies are solid-to-average; the whole complex is currently pressured by weak new construction and petrochemical input inflation, both of which are cyclical rather than structural.

4. Competitive Position

Applying the Greenwald taxonomy (economies of scale, customer captivity, cost advantage), Carlisle’s moat is real, concentrated in CCM, and evidenced in the financial outcomes.

Consolidated returns (ROIC.ai, reconciled to filings): ROIC of 8.7% (2021), 16.3% (2022), 14.0% (2023), 18.6% (2024), 17.0% (2025); ROE 10.1% / 19.6% / 14.2% / 20.9% / 10.4% (2025 ROE optically low because 2024 was inflated by the CIT divestiture gain — see the relevant section). Gross margin climbed from 28.6% (2020) to 35.7% (2025); operating margin from 12.3% to 20.0%. A ~17% ROIC on a ~9% WACC through a soft year is prima facie evidence of a durable advantage.

CCM commercial roofing — a genuine moat (economies of scale + brand/specification captivity + cost advantage). The mechanism passes the Greenwald tests:

• Economies of scale: national manufacturing and distribution density in a slow-growth replacement market. A sub-scale entrant cannot match Carlisle’s plant proximity, delivery reliability, product breadth, or specification presence at competitive unit cost — and in a market growing at re-roofing rates, incumbents defend share rather than invite a share war. Market-share stability among Carlisle/Holcim-Elevate/GAF/JM has been high for years.
• Customer captivity / switching costs: long-dated warranties (10–30 years) tie the building owner to the manufacturer; architects write Carlisle systems into specifications; and contractors are trained and certified on Carlisle systems (the “Carlisle Experience” — right product, right place, right time — is explicitly a labor-saving lock-in for contractors facing chronic labor shortages). Switching imposes real retraining, warranty, and specification-rewrite costs.
• Cost advantage: scale purchasing of petrochemical inputs; in-sourcing (e.g., in-house EPS resin from Plasti-Fab); and continuous productivity via the Carlisle Operating System (COS), which drove +50bps of margin in Q1-26 despite falling volume.

The proof is in pricing power and margin resilience: Carlisle pushed two 5–8% price increases in 2026 to offset petrochemical inflation and expanded CCM EBITDA margin in a down-volume quarter. Management’s line — “Carlisle has demonstrated exceptional margin sustainability” through the GFC, COVID, and now — is largely borne out by the through-cycle margin record. Verdict: durable moat.

CWT weatherproofing — weaker/emerging moat. CWT is a collection of building-envelope brands (Henry-led) in more fragmented, more competitive, more commoditized categories. Its ~15% margins vs CCM’s ~27% are the tell: less specification lock-in, more residential/new-construction exposure, more commodity input pass-through friction. Management’s margin-improvement program (automation, footprint consolidation, in-sourcing) is real self-help, but the segment does not yet demonstrate a durable moat — it is a scale-and-execution story, not a franchise. Verdict: moderate/emerging moat, execution-dependent.

Vs. competitors. Against Holcim/Elevate and GAF, Carlisle competes on brand, specification depth, product innovation (e.g., ThermaThin R7 high-R insulation), and warranty/service — not price. Its ~27% CCM margins are at or above peer commercial-roofing economics. The risk is not a challenger with a better mousetrap but (i) input-cost timing and (ii) distribution consolidation (QXO/Beacon) shifting channel power.

Greenwald franchise-value read. Under the Competition Demystified lens, the test of a genuine franchise is whether returns on capital persist above cost of capital because incumbents are protected by barriers to entry — and whether market shares are stable (the single most reliable sign of a real moat). CCM passes both: ROIC has sat in the mid-teens-to-high-teens through a full demand cycle (16.3% in the 2022 boom, 14.0% in the 2023 destock, 17.0% in the 2025 soft patch), and the manufacturer-level shares among Carlisle / Holcim-Elevate / GAF / Johns Manville have been strikingly stable for years — no disruptive new entrant has taken durable share, because the combination of national scale in a replacement market, specification/warranty lock-in, and petrochemical-input purchasing scale makes entry uneconomic. An earnings-power-value (EPV) framing reinforces the point: CCM’s ~$970M of segment EBITDA on modest maintenance capital implies a standalone franchise worth multiples of its invested capital — the excess of EPV over reproduction cost is the moat, and it is concentrated almost entirely in CCM. CWT, by contrast, earns closer to its cost of capital (~15% margins, execution-driven), so its EPV is much nearer its asset value — consistent with “emerging, not established” franchise status. The consolidated 17% ROIC is therefore a blended number hiding a wide-moat crown jewel and a fair-return second segment.

The share-stability caveat: distribution, not manufacturing. The one place the moat is genuinely contested is downstream: the roofing distribution channel is consolidating fast (QXO’s roll-up of Beacon; Home Depot’s purchase of SRS; QXO’s TopBuild deal), and Carlisle’s top-two customers now represent ~33% of revenue. Manufacturer-level share stability does not fully protect margins if a handful of mega-distributors gain leverage to demand price/rebate concessions. Management downplays this (reporting “great conversations” with QXO and noting limited overlap with the TopBuild/Beacon resi-fiberglass/shingle exposure), but it is the most credible medium-term threat to CCM’s pricing power — worth monitoring closely.

Verdict (competitive position): A durable, share-stable, high-ROIC moat in commercial re-roofing (CCM), carried by scale, specification/warranty captivity, and cost advantage; a weaker, execution-dependent position in CWT. Consolidated 17% ROIC is real and above WACC, and it is carried by CCM — which is precisely why a strategic acquirer covets scale in the space, and why Carlisle itself is now reaching for one.

5. Growth History and Forward Opportunities

History — a transformation, not smooth organic growth. Reported continuing-ops revenue reflects the portfolio reshaping: ~$3.84B (2021) → ~$5.45B (2022) → ~$4.59B (2023) → ~$5.00B (2024) → ~$5.02B (2025). The 2022 peak-and-2023 trough captures the post-COVID roofing super-cycle and its destock unwind; 2024–25 is roughly flat as new construction weakened and price offset volume. Adjusted EPS from continuing operations tells the cleaner story of earnings power: it has been range-bound around $17–18 for three years ($18.34 in 2024, $17.16 in 2025), with the compounding coming from buybacks, not organic EBITDA growth. This is the honest characterization: the underlying earnings engine has been flat-to-down through the 2024–25 soft patch, and per-share progress has been manufactured by an aggressive, well-executed buyback.

Forward opportunities — the Vision 2030 algorithm. Management’s framework targets $40 of adjusted EPS and 25%+ ROIC by 2030 — roughly a doubling of adjusted EPS from ~$17. The stated levers, in management’s words “flexible, independent levers” that need not all fire every year:

1. Organic growth from re-roofing — the aging installed base plus rising content per square foot (energy codes → more polyiso, higher-performance systems). Low-single-digit volume with mix/price uplift.
2. COS-driven margin expansion in both segments — the 2026 guide is ~50bps consolidated, with CWT the bigger opportunity (~15%→20%→mid-20s).
3. Buybacks — ~$1B/yr, shrinking the share count ~5%+ annually at the current price.
4. Synergistic bolt-on M&A — “when the right opportunities are available at the right price.”

Reality check on Vision 2030. Getting from ~$17 to $40 adjusted EPS by 2030 (~5 years) implies a ~19% EPS CAGR. Decompose it: buybacks at ~$1B/yr contribute perhaps 4–5%/yr; CWT margin recovery and COS add a few points of EBITDA growth; re-roofing volume + content add low-single-digits; the rest requires either a genuine new-construction recovery, meaningful margin expansion beyond guidance, or sizeable accretive M&A. It is an ambitious target that leans on continued buybacks and a cyclical recovery that has not yet arrived — which is the crux of the valuation debate. The Owens Corning bid is best read as management’s attempt to close the Vision-2030 gap with a transformational, rather than bolt-on, acquisition.

Decomposing the re-roofing tailwind. The bull case’s foundation deserves quantification. Two structural drivers compound: (1) Volume — a large, aging installed base of low-slope commercial roofs on a 20–25-year replacement cycle means a rising tonnage of roofs reaches end-of-life each year; management frames this as low-single-digit secular volume growth largely independent of GDP. (2) Content per square foot — tightening energy codes require thicker insulation (more polyiso board per roof), and higher-performance systems (reflective TPO, enhanced air/vapor barriers, better warranties) raise the dollar content of each re-roof. Layer in price (Carlisle’s demonstrated ability to pass petrochemical inflation through, e.g. two 5–8% 2026 increases) and pricing-for-value on new products (ThermaThin R7, FAST adhesive systems, SeamShield), and CCM can plausibly grow revenue at mid-single-digits through-cycle even with flat-to-soft new construction. This is a genuinely attractive organic algorithm — if the re-roof volume base holds. The Q1-26 “weather” softness is the reminder that even recurring demand has quarterly variance; the question is whether low-single-digit re-roof growth is durable or whether the 2020–21 super-cycle pulled forward replacement demand that now air-pockets.

The buyback’s role, quantified. Absent organic EBITDA growth, per-share compounding has come from the share count falling ~5%/yr. At ~$1B/yr against a ~$15B cap, that is ~6.5%/yr of gross repurchase, net ~5% share shrink after dilution — meaning even flat absolute earnings would deliver ~5% adjusted-EPS growth. This is real value creation (cash-funded, low dilution), but it is also why the “double-digit EPS growth” 2026 guide can be delivered on ~3% (all-price) revenue growth and ~50bps of margin — the arithmetic leans heavily on buyback and margin, not volume. Investors underwriting Vision 2030’s ~$40 EPS should be clear that a large chunk is financial (buyback) rather than fundamental (organic EBITDA), and that the buyback’s accretion degrades as the multiple rises.

Verdict: medium-quality growth. High-quality demand base (recurring re-roofing) but low-quality recent growth (per-share progress manufactured by buybacks against flat-to-down organic earnings). The forward opportunity is real but back-loaded and contingent on a recovery and/or M&A that the current price already largely credits.

6. Financial Quality

Revenue & margins. FY2025 net sales $5,019.9M (~flat YoY); gross margin 35.7% (down from 37.7% in 2024); operating margin 20.0% (down from 22.8%); adjusted EBITDA $1,225.4M at 24.4% margin, down 220bps — the clearest evidence that 2025 was a cyclically down year driven by soft new-construction volume and petrochemical input inflation outrunning price. Q1-2026 reversed the margin direction (+50bps to 22.3%) via COS productivity and pricing, supporting the recovery thesis.

The multi-year margin walk (why 2025 matters). Trace the operating margin: 12.3% (2020) → 14.9% (2021) → 22.1% (2022) → 21.4% (2023) → 22.8% (2024) → 20.0% (2025). The 2020→2022 surge was the post-COVID re-roofing super-cycle — pricing ran far ahead of cost as demand spiked and supply chains tightened. 2023 held as the mix stayed rich even through the destock. The 2024 print (22.8%) was near a cyclical peak. The 2025 step-down to 20.0% (and adjusted EBITDA margin from 26.6% to 24.4%) is the important datum: it is the first evidence that the super-cycle margin was partly transitory, unwinding as (i) new-construction volume fell and deleveraged fixed costs, and (ii) petrochemical inputs (MDI, TPO resin, polyols) re-inflated faster than price could catch. The bull reads 2025 as a trough to recover from (supported by Q1-26’s +50bps); the bear reads ~20% operating / ~24% EBITDA as closer to the normalized level than the 2024 peak — a ~200–250bps swing that, on ~$5B of revenue, is ~$100–125M of EBITDA, or roughly ~$2 of adjusted EPS. Which reading is right is the single most important quantitative question in the valuation.

Quality of earnings — two flags, both important:

• The 2024 GAAP EPS is not comparable. FY2024 GAAP diluted EPS of $27.85 is flattered by ~$447M (~$9.50/share) of gains from discontinued operations (the CIT divestiture to Amphenol). Continuing-operations adjusted EPS was $18.34. Anyone anchoring on “$28 in 2024 → $17 in 2025 = collapse” is misreading a one-time divestiture gain. The honest YoY is $18.34 → $17.16, a ~6% decline — meaningful, but not a collapse.
• Earnings power is flat-to-down, buyback carries per-share. Adjusted EPS: ~$16.5 (2022 cont-ops equiv) → ~$18.3 (2024) → $17.16 (2025). Net income (continuing) has not grown; the per-share line is held up by a ~5%/yr reduction in share count. Not a mirage (the buybacks are cash-funded and value-accretive at reasonable multiples), but investors should not confuse EPS growth with earnings growth here.

Free cash flow — genuinely strong and clean. FY2025 operating cash flow $1,101.8M, capex just $131.2M (~2.6% of sales) → FCF ~$970M, a ~6.5% FCF yield on the current ~$15B market cap and ~90%+ conversion of adjusted net income. SBC is small (~$35M, ~0.7% of sales) — this is not an SBC-flattered-FCF story; the buybacks genuinely shrink the share count rather than mopping up dilution. Capital intensity is low (unlike fiberglass insulators such as Owens Corning at ~8% of sales), a structural attraction of the membrane/adjacency model.

Balance sheet — conservative, with negative tangible book. FY2025: cash $1,112M, debt $2,881.6M → net debt ~$1.77B; net debt/EBITDA ~1.5x (management cites 1.7x at Q1-26, target range 1–2x). Investment-grade. Current ratio ~3.1x. Tangible common equity is negative (~−$1.2B): goodwill $1,539M + intangibles $1,425M (~$2.96B) exceed total equity of $1,795M, a legacy of the Henry/MTL/Plasti-Fab acquisitions and ~$6.1B of cumulative treasury-stock buybacks. Negative tangible book is common among serial acquirers that buy back stock and is not itself alarming given the FCF, but it means book-value and P/TBV metrics are meaningless here (P/TBV is negative) — value the cash flows, not the balance sheet.

ROIC/ROE. ROIC ~17% (2025), above WACC and toward the high end of the peer set; the Vision-2030 25%+ target would require both a cyclical recovery and margin expansion. ROE 10.4% (2025) is depressed by the 2024 comparison base and the large treasury-stock reduction of equity; on continuing operations the returns are healthy.

Verdict: high-quality economics, cyclically pressured. Real ROIC above WACC, excellent and clean FCF conversion, low capital intensity, conservative leverage, minimal dilution. The blemishes are honest ones: 2025 earnings declined, per-share growth is buyback-driven, and tangible book is negative. Do economics improve with scale? Yes — but they are currently at a cyclical low, not a high.

7. Capital Allocation

Capital allocation is Carlisle’s signature competency and the strongest pillar of the bull case — which is exactly why the Owens Corning bid is so consequential.

Returning cash — elite. Carlisle is a Dividend King: 49 consecutive years of dividend increases (quarterly dividend raised to $1.10/share in January 2026, ~$4.40 annualized, ~1.2% yield, ~24% payout — deliberately low to fund buybacks). Share repurchases are the main event: ~$1,300M in 2025, ~$1,586M in 2024, ~$900M in 2023, driving diluted share count from ~53M (2020) to ~41M (2025) — a ~22% reduction that is the primary source of per-share earnings growth. 2026 guidance reiterates a ~$1B annual buyback pace ($250M in Q1-26). Management is explicit that it will return capital “when that represents the highest and best use” — i.e., it treats buybacks as a residual, opportunistic use, and has historically bought more when the stock was cheaper.

Deploying cash — disciplined bolt-ons, one transformational reach. Post-Henry (2021, ~$1.57B), Carlisle’s M&A has been disciplined and successful bolt-ons: MTL Holdings (edge-metal, “exceptional in every way” per management), Plasti-Fab and ThermaFoam/Bonded Logic (EPS block insulation, enabling in-house resin vertical integration). Spend has been modest (~$110M in 2025, ~$677M in 2024, ~$36M in 2023) and management states acquisitions must “meet our stated criteria… at the right price.” The portfolio exits were equally disciplined and value-creating — divesting Brake & Friction, Fluid Technologies, and CIT (to Amphenol, ~$2.025B, 2024) to concentrate on the building envelope.

The Owens Corning bid — the discipline test. The 2026-06-29 report that Carlisle made multiple unsolicited >$10B offers for OC is a departure in scale from everything above. It is strategically coherent (OC’s residential shingles + fiberglass insulation would complement Carlisle’s commercial roofing and, arguably, help close the Vision-2030 gap) but financially fraught: at any real premium OC’s take-out EV (~$19–21B) approaches or exceeds Carlisle’s own market cap (~$15B), which would obliterate the 1–2x leverage target and/or require large equity issuance. The market’s reaction — CSL shares fell — is the correct instinct: this is where a disciplined capital allocator can either confirm its reputation (walk away, or structure a genuinely accretive deal) or squander it (overpay at a cyclical juncture). Interpretation: the single most important capital-allocation event in Carlisle’s recent history is now live and unresolved.

Incentive alignment — a governance gap. Here the story is more mixed than the marketing. The 2025 annual cash bonus keyed off Sales (25%), operating-income margin (20%), average working-capital % of sales (15%), and adjusted earnings (40%); long-term incentives are options + restricted shares + performance shares earned on relative TSR vs. the S&P MidCap 400. Notably, neither ROIC nor EPS — the two headline Vision-2030 targets — appears anywhere in the incentive plan. The “$40 adjusted EPS / 25%+ ROIC” framing is thus an investor-facing aspiration, not a contractually incentivized management scorecard — a real governance gap for a strategy built on returns on capital and per-share value. To the plan’s credit, pay-for-performance worked in the down year: all four 2025 annual metrics missed threshold (sales $4.99B vs $5.14B threshold; OI margin 20.5% vs 22.0%; adjusted earnings $759M vs $832M), so CEO Chris Koch and CFO Kevin Zdimal earned $0 annual bonus for 2025 (Koch total comp $11.4M, down from $14.2M). Relative TSR does loosely align management with shareholders (the 2023–25 PSU tranche paid 154% of target at the 63rd percentile). But say-on-pay support fell to ~77% at the 2025 meeting (versus a >90% five-year average) — a soft-controversy flag the company acknowledged via stockholder engagement.

Insider signal — no conviction buying. Across ~140 Form 4s from 2024–2026, there are zero open-market purchases (code P) by any officer or director. The pattern is textbook compensation-monetization: grants in (A), tax-withholding (F), option exercise (M) and same-day sale (S) — the CEO exercised and sold ~$24.5M in May 2024, the CFO a large exercise-and-sell in July 2024, and these sales are discretionary (not 10b5-1-planned) but tied to option expiries. Interpretation: no insider stepped in to buy the November-2025 ~$294 low with their own cash — a neutral-to-mildly-negative tell, consistent with a “fully-valued, not screaming-cheap” read.

Debt & liquidity. The balance sheet is conservatively levered: gross senior notes of ~$2.9B ($600M 3.75% 2027, $750M 2.75% 2030, $550M 2.20% 2032, $500M 5.25% 2035, $500M 5.55% 2040), ~$1.1B cash → net debt ~$1.77B (~1.45x net / ~1.7x per management), an undrawn $1.0B revolver, and no near-term maturity wall. Gross debt roughly doubled in 2025 via an August $1B notes issuance — the tell that recent buybacks were partly debt-funded, not purely FCF-funded, a modest ding to the “self-funding compounder” narrative and a reminder of how little balance-sheet room a >$10B OC deal would leave.

Verdict: historically excellent — now on trial. Through 2025, one of the best capital-allocation records in building products: elite, opportunistic buybacks; a 49-year dividend streak; disciplined, value-creating M&A and divestitures. The OC bid injects genuine uncertainty; the verdict on 2026 capital allocation is pending, and it is the swing factor for the thesis.

8. Changes and Headwinds — Last Two Years

1) Portfolio transformation completed (2024). The CIT divestiture to Amphenol (~$2.025B) completed Carlisle’s pivot to a pure-play building-envelope company. Thesis impact: positive — higher-quality, higher-margin, more focused business; but it reset the revenue base and made 2024 GAAP EPS non-comparable.

2) Cyclical downturn in new construction (2024–2025). Higher-for-longer rates pressured both residential and nonresidential new construction; distributors destocked; adjusted EBITDA fell ~8% in 2025 and the stock round-tripped from $471 to $294. Thesis impact: negative but cyclical — the re-roofing base held (low-single-digit growth), so the damage was to the cyclical half of demand, not the structural half.

3) Petrochemical input inflation (2026). Middle East escalation (Iran/Strait of Hormuz) drove oil and petrochemical-linked raws (MDI up double-digits, TPO resin up double-digits, polyols high-single-digits). Carlisle responded with two 5–8% price increases in CCM/CWT and freight surcharges; 2026 guide assumes price/cost roughly neutral for the year. Thesis impact: neutral-to-negative near-term — tests pricing power (so far holding) and makes the 2026 revenue guide “all price, no volume.”

4) Margin-recovery execution (2026). After the 2025 margin decline, management made profitability the top 2026 priority; Q1-26 delivered +50bps EBITDA margin on lower volume via COS. Thesis impact: positive — evidence the self-help levers work through the cycle; the reaffirmed guide (upper-end low-single-digit revenue, ~50bps margin, double-digit EPS growth) depends on it.

5) Distribution-channel consolidation. QXO acquired Beacon; Home Depot bought SRS; QXO also bought TopBuild. Thesis impact: mixed — concentrates customer/channel power (top-2 customers ~33% of sales), but management reports “great conversations” with QXO and notes the TopBuild/Beacon overlap is largely in resi fiberglass/shingles where Carlisle doesn’t play.

6) The Owens Corning bid (June 2026) — deeper analysis. This is the dominant near-term swing factor and deserves its own dissection. What was reported: on 2026-06-29 the WSJ said Carlisle made multiple unsolicited cash-and-stock offers, “well over $10 billion,” and that OC’s board “appears unreceptive.” Carlisle has filed nothing with the SEC (an unsolicited approach short of a signed deal or a 5% stake creates no filing obligation), so all facts are second-hand. Strategic fit (strong): OC brings the #2 U.S. residential-shingle franchise and #1 fiberglass insulation — complementary to Carlisle’s commercial roofing, giving a combined “whole-roof” platform and cross-sell into homebuilders and big-box channels. Financial strain (severe): OC’s take-out EV at a typical 25–35% premium is ~$19–21B — larger than Carlisle’s entire market cap (~$15B) and ~11–13x Carlisle’s own EBITDA. Financing options are all uncomfortable: an all-cash deal would take net leverage from ~1.7x to ~4–5x (through and above the stated 1–2x ceiling, likely a ratings downgrade), while a stock-heavy deal would issue Carlisle equity at ~14x EV/EBITDA to buy OC at ~7.5x — instantly dilutive to Carlisle’s multiple unless synergies are very large, and would roughly double the share count the company has spent years shrinking. Synergy math: even generous cost synergies (say $200–300M) capitalized at ~13x add ~$2.6–3.9B of value — meaningful, but not enough to bridge a ~$5–7B premium plus integration risk at a cyclical juncture. Antitrust: commercial-membrane + residential-shingle overlap is limited (different products), so the deal is more complementary than horizontal — regulatory risk is probably manageable, which is not the binding constraint; financing and price are. Probability/read: with an unreceptive board and a bidder near its financing ceiling, a completed deal is far from certain; the most likely outcomes are (a) Carlisle walks (neutral-to-positive for CSL — reaffirms discipline), (b) a protracted pursuit that pressures CSL on overpayment fears, or © a deal that, if struck at a full price with heavy leverage, would be the biggest risk to the thesis in a decade. Thesis impact: the dominant near-term swing factor — and the live test of the capital-discipline premium that underpins the entire bull case.

Verdict: The durable half of the business (commercial re-roofing) strengthened via portfolio focus and margin execution; the cyclical half (new construction) weakened on rates and input inflation. Net, the franchise is higher-quality than two years ago, but the near-term earnings are cyclically depressed and the OC bid injects real uncertainty into the capital-allocation story that underpins the whole thesis.

9. Risk Analysis (Risk Matrix)

Catastrophic-loss risk: low. Carlisle is a profitable, cash-generative, investment-grade market leader with a recurring demand base and conservative leverage — a permanent-impairment scenario would require either a grossly overpaid, badly-financed OC acquisition or a structural collapse in commercial re-roofing demand, neither of which is the base case. The realistic downside is a valuation de-rate plus a cyclical earnings trough, not a wipeout.

10. Valuation Discussion (Embedded Expectations)

Where the multiple sits. At ~$367, Carlisle trades at:

• ~21x adjusted EPS ($17.16, FY2025) — AZI P/E percentile 67th of its own 10-year range;
• ~14x EV/EBITDA (EV ~$17B / TTM adj. EBITDA ~$1.2B) — toward the upper end of its post-2022 range (which spanned ~10x in the 2022 trough to ~14x in 2024);
• ~6.5% FCF yield; ~1.2% dividend yield;
• P/S 3.1x (82nd percentile), P/B 6.0x (79th percentile), composite valuation-index percentile 76th — i.e., the stock is priced toward the rich end of its own history, on lower earnings.

What the price is underwriting. A ~14x EV/EBITDA, ~21x adjusted-EPS multiple on a company whose adjusted EBITDA and EPS fell in 2025 embeds meaningful confidence that (i) 2025 was a cyclical trough, (ii) the margin-recovery and COS levers deliver the reaffirmed ~50bps/yr expansion, (iii) buybacks continue at ~$1B/yr, and (iv) the Vision-2030 progression toward $40 adjusted EPS is credible. The market is, in effect, paying a premium multiple for the algorithm (recurring re-roof + margin + buyback) and looking through the cyclical soft patch. Notably, unlike a takeover target, Carlisle as acquirer carries negative optionality from the OC bid — the risk of overpayment/leverage, not a premium — which is why the shares fell.

Scenario analysis (illustrative, 2–4 year horizon; not a price target):

The asymmetry at ~$367 is unremarkable: the base case is “compound at a full multiple” (fine, not cheap), the bear case is a ~25–30% de-rate to the recent trough, and the bull case requires either a genuine construction recovery or a well-executed transformational deal. That is a HOLD configuration — a wonderful business at a price that already credits the recovery.

Reverse-DCF / embedded-expectations math. Strip the valuation to its skeleton. At ~$367 with ~41M shares, equity value is ~$15.0B and EV ~$17.1B. Against ~$970M of FCF, the market pays ~15.5x FCF (a ~6.5% FCF yield). For that to be merely fair against an ~8–9% cost of equity, Carlisle must grow FCF/share at roughly ~2.5–3.5% real in perpetuity — which, decomposed, is trivially cleared by the buyback alone (~5%/yr share shrink at $1B/yr) if absolute FCF merely holds flat. So on a pure buyback-math basis the stock is not obviously expensive — the ~$1B/yr repurchase does much of the heavy lifting. The catch is threefold: (i) the buyback math only works while the stock stays near this level (buying back at ~21x adjusted EPS is far less accretive than the ~13x paid during the 2022 trough — management’s own opportunism argues against aggressive repurchase here); (ii) it assumes absolute FCF holds, whereas 2025 FCF was cyclically supported by working-capital release and adjusted EBITDA fell ~8%; and (iii) the debt-funded portion of recent buybacks (Aug-2025 $1B notes) is not repeatable without stressing leverage — especially alongside a possible OC deal. Put differently: the price embeds “flat-to-modestly-growing FCF plus a continued ~$1B/yr accretive buyback plus no value-destructive OC deal.” None of those is heroic; all three are contestable, which is why the risk/reward is balanced rather than compelling at ~$367.

Sum-of-the-parts sanity check. CCM (~$3.6B sales at ~27% EBITDA ≈ ~$970M segment EBITDA) is the crown jewel — a commercial-roofing franchise standalone peers (and the strategic logic of the OC bid) would value at ~13–16x, i.e. ~$12.5–15.5B. CWT (~$1.4B sales at ~15% ≈ ~$210M EBITDA, improving toward ~$280M at 20%) is worth perhaps ~$2.5–4.0B at ~10–14x depending on the margin ramp. That frames a ~$15–19.5B enterprise range centered near the current ~$17.1B EV — i.e., the market is paying roughly fair value for the parts, with the CWT margin ramp and the buyback as the swing factors, and little embedded discount.

Peer comparison (illustrative, approximate current multiples):

(Multiples are approximate and for framing only; margins/ROIC from ROIC.ai where available.) The takeaway: Carlisle sits at the upper end of a 10–15x building-products band — deserved on margin/ROIC/capital-allocation quality, but with no discount — while its own target (OC) trades at roughly half its EV/EBITDA multiple, the crux of the deal-arithmetic problem.

Comps. Factor-similar and sector peers (RPM, Eagle Materials, Advanced Drainage, Owens Corning, and building-products compounders like Masco, Simpson, Allegion) generally trade 12–16x EV/EBITDA; Carlisle at ~14x is mid-to-upper — a fair-to-full multiple for a franchise with above-average margins, ROIC, and capital-allocation pedigree, but no obvious discount to exploit. Note the asymmetry vs. its own target: Carlisle-the-acquirer trades at ~14x EV/EBITDA while Owens Corning-the-target trades at only ~7.4–7.9x (per comparable roofing analysis) — the ~2x multiple gap is precisely why an all-stock OC deal would be dilutive to Carlisle’s multiple unless very large synergies are underwritten, and why a cash deal would balloon leverage. The comp set offers no cheap entry and the deal arithmetic offers no free lunch.

Verdict: Full, not cheap. The valuation embeds the recovery and the compounding algorithm; the margin of safety is thin at ~$367 and improves materially below ~$320–330 (~13x EV/EBITDA), with the November-2025 ~$294 level marking where the risk/reward last turned clearly attractive.

11. Variant Perception

Consensus view. Carlisle is a best-in-class building-products compounder — wide moat in commercial re-roofing, elite capital allocation, Dividend King, Vision-2030 path to $40 EPS — deserving a premium multiple; the 2025 softness is a cyclical trough to look through, and 2026 margin recovery confirms the algorithm.

Strongest bull case. The recurring re-roofing base (~70% of CCM) is a genuine annuity with an aging-installed-base tailwind and rising content per square foot; COS delivers structural margin expansion (proven again in Q1-26); ~$1B/yr buybacks compound per-share value ~5%/yr; the balance sheet is conservative; and management’s capital-allocation record earns the benefit of the doubt on Vision 2030. If new construction recovers and CWT margins normalize, the earnings base steps up materially and the premium multiple is justified.

Strongest bear case. You are paying ~21x adjusted EPS and ~14x EV/EBITDA — the 76th percentile of the stock’s own range — for a business whose earnings fell in 2025 and whose 2026 growth is all price, no volume. Per-share growth for three years has been manufactured by buybacks against flat organic earnings; the “growth” is financial engineering on a cyclical trough. And the single greatest asset — capital discipline — is now in question because management is chasing a >$10B bet-the-company acquisition of Owens Corning at a cyclical juncture. Multiple compression + a value-destructive deal is a plausible path to a ~25–35% drawdown.

The 3–5 assumptions that matter most:

1. Re-roofing demand is a durable, growing annuity (the whole moat). Falsifier: CCM re-roof volume turns negative for consecutive quarters.
2. 2025 was a cyclical trough, not a new normal — margins and volume recover. Falsifier: 2026 margin expansion fails to materialize; adjusted EBITDA declines again.
3. Capital discipline holds on the OC bid. Falsifier: Carlisle closes a >$10B OC deal at a full price with heavy leverage/dilution.
4. Buybacks continue at ~$1B/yr and remain accretive. Falsifier: buybacks paused/cut to fund M&A or de-lever.
5. Pricing power offsets petrochemical inflation. Falsifier: price/cost turns persistently negative; margins crack below ~22%.

Factor-positioning read (FactorsToday). Carlisle screens as a market/cyclical name (market beta ~1.05–1.2 depending on model; sector/industrials loading) with no meaningful momentum loading and a small negative alpha — consistent with a quality-cyclical, not a crowded momentum trade. Risk-adjusted history is solid but unspectacular (5-year Sharpe ~0.43, 5-year annualized return ~15%), and the trailing 12-month relative strength is negative (~−6%) even as the last 3–6 months rebounded hard off the November low (m3 ~+52% annualized, m6 ~+33% annualized). Max drawdown over five years ~−38%. Interpretation: the tape describes a high-quality cyclical that de-rated through 2025 and is bouncing — recovering, not euphoric; the recent strength is a mean-reversion off an oversold trough plus an M&A jolt, not a durable momentum regime. This supports the “full price on a recovering-but-unproven earnings base” read rather than either a falling-knife or a runaway-momentum framing.

Where consensus may be offsides: it likely under-weights (a) how much of “growth” is buyback-manufactured on flat organic earnings, and (b) the real, newly-elevated capital-allocation risk from the OC bid — both of which argue the premium multiple is vulnerable if the recovery slips or the deal turns adverse.

12. Fact vs. Interpretation Table

13. Open Questions

1. The Owens Corning bid: Will Carlisle pursue, raise, or walk? How would it be financed (debt vs. equity), at what leverage, and at what premium? Does OC’s board engage, or does a competing bidder / regulatory issue emerge? This is the single largest unknown.
2. Incentive-plan metrics (resolved — flag): The plan keys off Sales / OI-margin / working-capital / adjusted-earnings (annual) and relative TSR (long-term) — not ROIC or EPS, despite Vision 2030’s headline targets. Open sub-question: will the board add an ROIC/EPS gate, and does the current design bias management toward a scale-adding OC deal (sales/absolute-earnings metrics reward size)?
3. Insider behavior (resolved): No open-market purchases on the November-2025 dip — only routine option-exercise-and-sell. No insider conviction signal to lean on.
4. CWT margin trajectory: Does CWT actually reach ~20% in 2026 and “mid-20s” thereafter, or does soft residential demand stall the self-help story?
5. Price/cost through 2026: Do the two 2026 price increases fully stick and hold margins neutral if petrochemical inflation persists?
6. Re-roofing volume: Is the low-single-digit re-roof growth durable, or was the Q1-26 softness more than “weather”?
7. Normalized earnings power: Is ~$17 adjusted EPS the trough or the new base? The valuation depends heavily on the answer.

14. What Must Be True

Bull case — what must be true:

• Commercial re-roofing remains a growing, non-discretionary annuity (aging installed base + content/sqft), delivering durable low-single-digit-plus volume with pricing power.
• The margin-recovery/COS levers deliver the reaffirmed ~50bps/yr expansion, and CWT climbs toward mid-20s margins.
• Management maintains capital discipline — either walking from OC or structuring a genuinely accretive deal — while continuing ~$1B/yr accretive buybacks.
• 2025 proves to be a cyclical trough; a new-construction recovery eventually lifts the earnings base toward the Vision-2030 path.
• Falsification test: two-plus consecutive quarters of negative CCM re-roofing volume, or a >$10B OC deal closed at a full price with leverage to ≥3x — either would break the “disciplined compounder with a durable annuity” thesis.

Bear case — what must be true:

• The premium multiple (~14x EV/EBITDA, 76th percentile) compresses as the market recognizes that per-share growth is buyback-manufactured on flat-to-down organic earnings.
• New construction stays weak, petrochemical inflation outruns price, and adjusted EBITDA declines again or stalls.
• Management overpays for Owens Corning, levering up at a cyclical juncture and destroying the capital-discipline premium.
• Falsification test: CCM re-roof volume re-accelerates, 2026 margins expand as guided, and Carlisle either walks from OC or structures it accretively — which would validate the compounder thesis and justify the multiple, breaking the bear case.

15. Source Appendix

See Appendix B below for the full list of primary and secondary sources with URLs and access dates. Principal sources: Carlisle FY2021–FY2025 Forms 10-K and FY2026 Q1 10-Q (SEC EDGAR, CIK 0000790051); Q1-2026 and prior earnings-call transcripts (ROIC.ai); ROIC.ai fundamentals, ratios, enterprise value and valuation multiples; AZI price history and valuation-index percentiles and news feed (incl. 2026-06-29 WSJ Owens Corning bid reports); FactorsToday factor model; and public reporting on the Carlisle–Owens Corning approach (WSJ, 2026-06-29) and Owens Corning’s own filings for roofing-industry structure and the bid.

---

# APPENDIX A — Standard Diligence Questionnaire

## Carlisle Companies Incorporated (NYSE: CSL) — 2026-07-04

Supplemental to the analysis. Answers are grounded in the underlying research, labeled Fact / Interpretation / Assumption where it matters.

### General
**What thoughtful questions have other investors asked?**
- Is \~$17 adjusted EPS the cyclical *trough* or the new *base*? (The entire valuation debate.)
- How much of "growth" is organic vs. buyback-manufactured? (Answer: for 3 years, per-share growth is essentially all buyback.)
- Will Carlisle stay disciplined on the Owens Corning bid, or overpay for scale? (The 2026-06-29 news made this the dominant question.)
- Can CWT margins actually reach the "mid-20s," or is \~15% structural?
- Does the \~70% re-roofing mix truly insulate CCM from the construction cycle? (Q1-26 "weather" softness raised the question.)

### Cyclicality & Earnings Nature
- **Cyclical high or low?** *Low.* Adjusted EBITDA fell \~8% and adjusted EPS \~6% in 2025 on weak new construction and input inflation; 2026 is guided to recovery. Earnings are cyclically depressed, not peaked (Fact/Interpretation).
- **External environment or internal actions?** Both — the *downturn* was external (rates → weak construction; petrochemical inflation); the *margin recovery* is internal (COS productivity, pricing, footprint/automation). (Interpretation)
- **How stable are revenues?** The \~70% re-roofing base of CCM is stable/recurring (20–25-yr replacement cycle); the new-construction \~30% and much of CWT are cyclical. Blended, more stable than a typical building-products name but not defensive.
- **Product/market outlook & size:** U.S. commercial roofing \~$20B+; secular content-per-sqft growth from energy codes; aging installed base drives replacement. Mostly North American (>90% of revenue) — deliberate. Growing low-single-digits structurally.

### Business Quality & Competitive Moat
- **Industry more or less competitive?** Stable oligopoly at the membrane-manufacturer level (Carlisle, Holcim/Elevate, GAF, JM); distribution is *consolidating* (QXO/Beacon, HD/SRS), shifting some power to the channel.
- **How profitable (ROIC/ROE)?** ROIC \~17% (2025), above \~8–9% WACC; CCM segment EBITDA margin \~27%; consolidated adj. EBITDA margin 24.4%. Genuinely high-return. (Fact)
- **Industry profitability / barriers:** High for scaled, vertically-integrated membrane makers; barriers = scale, specification/warranty captivity, brand, distribution relationships, and (increasingly) product innovation/energy performance.
- **Understandable?** Yes — a focused building-envelope manufacturer.
- **Foreign low-cost labor threat?** Low — bulky, freight-sensitive products favor regional manufacturing; specification/warranty/service lock-in is local.
- **Do brands matter?** Yes — Carlisle SynTec, Versico, Hunter, Henry carry specification and warranty weight with architects/contractors/building owners.
- **Nature of competition:** Brand, specification, product innovation, warranty, and service ("Carlisle Experience"), *not* price. Two 2026 price increases held.
- **Switching costs:** Real — retraining/certification of contractors, specification rewrites, warranty continuity.

### Financial Condition & Balance Sheet
- **Assets not on the balance sheet?** The brand/specification franchise and the installed-base warranty relationships are not capitalized. (Interpretation)
- **Off-balance-sheet liabilities?** Standard operating leases; long-dated product warranties (accrued). No unusual items flagged.
- **Accounting conservatism?** Reasonable; clear GAAP-to-adjusted reconciliation. The one caution: 2024 GAAP EPS ($27.85) includes a large CIT discontinued-ops gain — headline figures require care. SBC is small (\~$35M).
- **CapEx-hungry?** No — capex \~2.6% of sales (\~$131M), far lighter than fiberglass insulators (\~8%). A structural FCF advantage.

### Capital Allocation & Management
- **FCF & its use:** \~$970M FCF in 2025; used for buybacks (\~$1.3B, partly debt-funded), dividends (\~$181M), and bolt-on M&A (\~$110M). Philosophy (management): capital allocation as a "core competency"; returns over growth; buybacks as an opportunistic residual. (Fact/Interpretation)
- **Significant acquisitions recently?** Bolt-ons (MTL, Plasti-Fab, ThermaFoam/Bonded Logic); Henry (2021, \~$1.57B) built CWT. **Unresolved:** the reported unsolicited **>$10B Owens Corning** approach (2026-06-29) — transformational, not a bolt-on.
- **Buying back shares?** Aggressively — share count \~53M→41M since 2020 (\~22%); \~$1B/yr pace guided for 2026. The primary EPS driver.
- **Issuing shares to insiders?** Minimal — SBC \~0.7% of sales; buybacks vastly exceed dilution.
- **Compensation / incentive metrics:** Annual bonus keys off Sales (25%), OI margin (20%), working-capital % (15%), adjusted earnings (40%); LTI = options + restricted shares + performance shares on relative TSR vs. S&P MidCap 400. **Neither ROIC nor EPS is in the plan**, despite Vision 2030's headline targets — a governance gap. Pay-for-performance did work: all 2025 metrics missed threshold, so CEO/CFO earned **$0 annual bonus** (Koch total comp $11.4M). Say-on-pay support fell to **\~77%** (from >90%). (Fact)
- **Insider behavior:** Zero open-market purchases 2024–26; CEO/CFO are discretionary net-sellers via option monetization (non-10b5-1). No conviction-buy signal.
- **Management motivations:** A long-tenured team (CEO Chris Koch) with a strong through-cycle capital-allocation reputation — now being tested by the OC bid; note the size-rewarding comp metrics could bias toward a scale-adding acquisition.

### Valuation & Market Data
- **ADR / MLP / K-1?** No — U.S. C-corp, NYSE-listed common stock; standard 1099 dividend.
- **Dividend policy:** Dividend King — 49 consecutive annual increases; \~$4.40/yr (\~1.2% yield), \~24% payout (kept low to fund buybacks).
- **Profitability:** High — ROIC \~17%, adj. EBITDA margin 24.4%, gross margin 35.7%.
- **NI vs. CFO divergence?** No red flag — 2025 CFO ($1,101.8M) exceeds net income ($740.7M); FCF conversion \~90%+ of adjusted earnings. Clean.

### Risks & Downside
- **What would cause the stock to decline?** (i) A value-destructive/over-levered OC acquisition; (ii) multiple compression from the 76th-percentile valuation; (iii) prolonged new-construction weakness / another down earnings year; (iv) petrochemical inflation outrunning price; (v) re-roofing volume disappointing.
- **Catastrophic-loss risk?** Low — profitable, cash-generative, investment-grade leader with a recurring demand base. Realistic downside is a de-rate + cyclical trough (\~25–35%), not a wipeout.
- **Total-loss risk?** Negligible absent a grossly mis-financed transformational deal.

### Recent News & Events
- **Environment changed recently?** Yes — the **2026-06-29 WSJ report of Carlisle's unsolicited >$10B bid for Owens Corning** is the dominant recent event (CSL shares fell). Also: petrochemical input inflation (Iran/Hormuz) and two 2026 price increases; Q1-26 margin recovery (+50bps); continued buyback.
- **Significant acquisitions/divestitures?** CIT sold to Amphenol (\~$2.025B, 2024) completed the pure-play pivot; bolt-ons ongoing; OC approach pending.
- **Accounting-policy changes?** None material flagged; segment reporting reflects the two-segment (CCM/CWT) structure post-transformation.
- **New markets/facilities/management?** Footprint consolidation and automation in CWT; in-house EPS resin (Plasti-Fab); new products (ThermaThin R7 insulation). Long-tenured management team intact.


---

# APPENDIX B — Source Appendix
## Carlisle Companies Incorporated (NYSE: CSL) — Research Initiation, 2026-07-04

All non-obvious facts in this article trace to a source below. Primary sources (SEC filings, company disclosures, earnings-call transcripts) are prioritized over secondary. Third-party aggregated data (ROIC.ai, AZI, FactorsToday) is used for computed ratios/prices and reconciled to filings; where they disagree with a filing, the filing governs.

### Primary — SEC filings (EDGAR, CIK 0000790051; corpus mirrored locally)
- **Form 10-K, FY2025** (filed 2026-02-13, `csl-20251231`) — segment structure (CCM/CWT), adjusted EBITDA ($1,225.4M, 24.4% margin) and adjusted EPS from continuing ops ($17.16 vs $18.34); capital expenditures ($131.2M / $113.3M / $142.2M for 2025/24/23); "increased our dividend rate annually for the past 49 years"; $1.10/quarter dividend declared 2026-01-28; two largest customers \~33% of consolidated revenues; key raw materials (MDI, TPO resin, polyols); acquisitions net of cash ($109.6M / $676.9M / $36.1M). https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000790051&type=10-K
- **Forms 10-K, FY2021–FY2024** (`csl-2021…2024-1231`) — multi-year revenue, margin, and portfolio-transformation history (Brake & Friction, Fluid Technologies, CIT divestitures; Henry acquisition).
- **Form 10-Q, Q1 FY2026** (filed 2026-04) — Q1-26 segment revenue/margin, net debt/EBITDA 1.7x, cash $771M, buyback pace.
- **DEF 14A / DEFA14A proxy statements (2022–2026)** — executive compensation and incentive metrics; board composition. (See Diligence Appendix / SEC sweep.)
- **Form 4 insider filings (2024–2026)** — officer/director transactions; insider-signal read. (See Diligence Appendix.)
- Accessed 2026-07-04.

### Primary — Earnings-call transcripts (ROIC.ai)
- **Q1 2026 earnings call, 2026-04-23** (Chris Koch, CEO; Kevin Zdimal, CFO) — \~70% of CCM is commercial re-roofing; 20–25-year roof cycle; Vision 2030 targets ($40 adj. EPS, 25%+ ROIC); reaffirmed 2026 guide (upper-end low-single-digit revenue, \~50bps margin, double-digit EPS growth); two 5–8% price increases; raw-material inflation (MDI/TPO/polyols double-/high-single-digit); net debt/EBITDA 1.7x; \~$1B/yr buyback ($250M Q1); CWT margin path (15%→20%→mid-20s); QXO/Beacon distribution commentary; ABI \~49.8.
- **Q4 2025 / Q3 2025 / prior calls (2021–2026)** — enumerated via ROIC `list_earnings_calls`; used for cycle and margin trajectory.

### Third-party quantitative (reconciled to filings)
- **ROIC.ai MCP** — income statement, balance sheet, cash flow (FY2020–FY2025); profitability ratios (ROIC 17.0% 2025; ROE; margins); enterprise value ($15.46B at FY2025 year-end; market cap; EV/EBITDA 12.9x); valuation multiples (own-history last/avg/high/low). Accessed 2026-07-04.
- **AZI (azitrading.com)** — daily price CSV (adjusted OHLCV, EMAs, beta 1.05); `valuation_index` own-history percentiles (P/E 67th, P/B 79th, P/S 82nd, composite 76th; TTM EPS $16.96, book $60.94, sales/sh $116.92; as of 2026-07-02); news feed. Accessed 2026-07-04.
- **FactorsToday (factorstoday.com/api)** — stock loadings (market beta \~1.05–1.2; no momentum loading), leaderboard (5yr Sharpe \~0.43, 5yr return \~15%, max drawdown \~−38%; m3 +52%/m6 +33% annualized rebound; y1 \~−6%), stock-info (rs_12m −4.83, rs_peak −22.21), related stocks (RPM, EXP, MLM, WMS, OC). Accessed 2026-07-04.

### Secondary — news / industry
- **The Wall Street Journal**, reported via AZI/Benzinga news feed, **2026-06-29** — "Carlisle Made Multiple Unsolicited Offers To Acquire Owens Corning" in a "well over $10 billion" cash-and-stock deal; OC "appears unreceptive"; CSL shares traded lower (article IDs 410787/410853/410893). https://azitrading.com
- **AZI news feed** — industrial-sector price-action items (oil/Iran, 2026-06-10/06-15).
- Commercial-roofing industry structure (single-ply membrane oligopoly: Carlisle SynTec/Versico/WeatherBond, Holcim/Elevate [ex-Firestone], GAF Commercial, Johns Manville, Mule-Hide) — synthesized from company filings, Owens Corning's public filings, and industry trade sources; treated as Interpretation where not directly filed.